Kiniksa Pharmaceuticals International, plc Annual Share-based Payment Arrangement, Expense in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Kiniksa Pharmaceuticals International, plc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2017 to 2023.
  • Kiniksa Pharmaceuticals International, plc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $7.83M, a 15.3% increase year-over-year.
  • Kiniksa Pharmaceuticals International, plc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $30.2M, a 17.2% increase year-over-year.
  • Kiniksa Pharmaceuticals International, plc annual Share-based Payment Arrangement, Expense for 2023 was $27.1M, a 8.08% increase from 2022.
  • Kiniksa Pharmaceuticals International, plc annual Share-based Payment Arrangement, Expense for 2022 was $25.1M, a 0.21% decline from 2021.
  • Kiniksa Pharmaceuticals International, plc annual Share-based Payment Arrangement, Expense for 2021 was $25.2M, a 20.6% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $27.1M +$2.03M +8.08% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $25.1M -$53K -0.21% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $25.2M +$4.3M +20.6% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $20.9M +$5.8M +38.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-02
2019 $15.1M +$9.38M +165% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $5.7M +$4.8M +536% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $897K Jan 1, 2017 Dec 31, 2017 10-K 2019-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.